Attached files
| file | filename |
|---|---|
| EX-31.2 - RespireRx Pharmaceuticals Inc. | ex31-2.htm |
| EX-31.1 - RespireRx Pharmaceuticals Inc. | ex31-1.htm |
| EX-23.1 - RespireRx Pharmaceuticals Inc. | ex23-1.htm |
| EX-21 - RespireRx Pharmaceuticals Inc. | ex21.htm |
| EX-4.3 - RespireRx Pharmaceuticals Inc. | ex4-3.htm |
| 10-K - RespireRx Pharmaceuticals Inc. | form10-k.htm |
EXHIBIT 32
CERTIFICATION
Arnold S. Lippa, Ph.D., Interim President, Interim Chief Executive Officer, Chief Scientific Officer, Director and Executive Chairman of the Board of RespireRx Pharmaceuticals Inc. (the “Company”), and Jeff E. Margolis, Senior Vice President, Chief Financial Officer, Treasurer and Secretary of the Company, each hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, 18 U.S.C. Section 1350, that:
| (1) | the Annual Report on Form 10-K of the Company for the year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: April 14, 2020 | /s/ Arnold S. Lippa, Ph.D. |
| Arnold S. Lippa, Ph.D. | |
| Interim President, Interim Chief Executive Officer, Chief Scientific Officer, Director and Executive Chairman of the Board | |
| Dated: April 14, 2020 | /s/ Jeff E. Margolis |
| Jeff E. Margolis | |
| Senior Vice President, Chief Financial Officer, Treasurer and Secretary |
This certification accompanies the Annual Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.